EA4232: Peripheral T Cell Lymphoma - Clinical Trial

If you choose to join this study, you will get a random assignment (by chance) to 1 of 2 groups:

• Group 1: If you are in this group, you will be observed once a year without any additional treatments unless your disease recurs. If that were to occur, you would be treated under your cancer doctor's guidance, which may also include the possibility of receiving a stem cell transplant as an option if you are eligible for it.
• Group 2: If you are in this group, you will undergo stem cell collection, then you will receive high dose chemotherapy followed by getting your own stem cells as an infusion. You will receive the necessary supportive care measures after that until your transplanted stem cells recover. You will then be observed without any additional treatments unless your disease recurs.